Antiplatelet Medication in Adult Moyamoya Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease
Sci Rep 2021 Sep 29;[EPub Ahead of Print], CH Pang, WS Cho, HS Kang, JE KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.